Favorable pathologic and long-term outcomes from the conventional approach to abdominoperineal resection

Diseases of the Colon and Rectum

Volumn 54, Issue 7, 2011, Pages 793-802

  Messenger, David E ^a   Cohen, Zane ^a,c   Kirsch, Richard ^a,c   O'Connor, Brenda I ^a   Victor, J Charles ^b   Huang, Harden ^a   McLeod, Robin S ^a,c,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Rectal cancer; Surgical oncology

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANADA; CANCER STAGING; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; CORNEA DISEASE; DATA BASE; DISEASE FREE SURVIVAL; FEMALE; HEMATOMA; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PERFORATION; POSTOPERATIVE HEMORRHAGE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM CARCINOMA; RECURRENT DISEASE; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; SURGICAL APPROACH; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND INFECTION; ABDOMEN; ADENOCARCINOMA; COLON RESECTION; COMPARATIVE STUDY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PERINEUM; RECTUM TUMOR; TIME;

ABDOMEN; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERINEUM; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051561224     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e318215a1cb     Document Type: Article

References (19)

1. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93-96. (Pubitemid 30438509)
2. Kapiteijn E, Putter H, van de Velde CJ; Cooperative investigators of the Dutch Colorectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg. 2002; 89:1142-1149. (Pubitemid 34989221)
3. Wibe A, Møller B, Norstein J, et al. A national strategic change in treatment policy for rectal cancer: implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45:857-866. (Pubitemid 34761463)
4. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P; Dutch Colorectal Cancer Group, Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257-9264.
5. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide O. Oncological outcomes after total mesorectal excision for cure of the lower rectum: anterior vs abdominoperineal resection. Dis Colon Rectum. 2004;47:48-58. (Pubitemid 38040245)
6. Tekkis PP, Heriot AG, Smith J Thompson MR, Finan P, Stamatakis JD. Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis. 2005;7:369-374. (Pubitemid 40894866)
7. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74-82. (Pubitemid 40917970)
8. Killeen SD, O'Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92:389-402. (Pubitemid 40523899)
9. Figueredo A, Rumble RB, Maroun J, et al. Follow-up of Patients with Curatively Resected Colorectal Cancer: Practice Guideline Report #2-9, 2004. http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId-14014. Accessed September 5, 2010.
10. Holm T, Ljung A, Ḧggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor and rectal cancer. Br J Surg. 2007;94: 232-238. (Pubitemid 46340406)
11. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008;26: 3517-3522.
12. Dehni N, McFadden N, McNamara DA, Guiguet M, Tiret E, Parc R. Oncologic results following abdominoperineal resection for adenocarcinoma of the low rectum. Dis Colon Rectum. 2003; 46:867-874. (Pubitemid 36875480)
13. West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal resection for low rectal cancer. Br J Surg. 2010;97:588-599.
14. Davies M, Harries D, Hirst G, et al. Local recurrence after abdomino-perineal resection. Colorectal Dis. 2009;11:39-43.
15. Bebenek M. Abdominosacral amputation of the rectum for low rectal cancers: ten years of experience. Ann Surg Oncol. 2009;16: 2211-2217.
16. Chuwa EW, Seow-Choen F. Outcomes for abdominoperineal resections are not worse than those of anterior resections. Dis Colon Rectum. 2006;49:41-49. (Pubitemid 41830654)
17. den Dulk M, Marijnen CA, Putter H, et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg. 2007;246:83-90. (Pubitemid 47012211)
18. Archampong D, Borowski DW, Dickinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341-352.
19. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006; 333:779.